Transforming Healthcare with AI: SBC Medical Group Appoints Sheng-FU Hsiao as CTO
SBC Medical Group Holdings Incorporated has appointed Sheng-FU Hsiao as its Chief Technology Officer (CTO) effective March 1, 2026, in line with the Company's management strategy focused on AI and DX. This move aims to enhance the leadership team to drive technological transformation within the medical industry. SBC Medical is shifting towards an AI-driven infrastructure to address challenges related to productivity, quality, and transparency, aiming to establish an "Automated Management Infrastructure" for optimized decision support and operational execution.
Mr. Hsiao, with a background in leading AI-specialized organizations and implementing IT governance for pre-IPO companies, will spearhead the modernization of core systems at SBC Medical. His expertise in automating large-scale operations and modernizing legacy systems will be instrumental in transforming the Group's data into a strategic AI asset while upholding security, ethics, and data governance standards.
Collaborating with Vice President Yuya Yoshida, Mr. Hsiao will drive the Group's AI strategy, integrating the vision of the "SBC AI Lab" with technical execution capabilities to redesign the management "OS" for enhanced operational efficiency. The implementation of an AI-driven infrastructure aims to optimize processes across various clinic operations, enhance medical transparency, and expand globally.
SBC Medical Group Holdings Incorporated operates a diverse portfolio of clinic brands across medical fields such as aesthetic medicine, dermatology, orthopedics, fertility treatment, dentistry, AGA (hair restoration), and ophthalmology. The Company is focused on providing safe, trusted, and high-quality medical services globally while strengthening its international reputation for quality and trust in medical care. For more information, visit [website].
In conclusion, SBC Medical's appointment of Sheng-FU Hsiao as CTO signifies a strategic move towards leveraging AI and technology to drive innovation and efficiency in the medical industry. With a focus on modernizing core systems and optimizing operational processes, the Company aims to enhance its global presence and deliver high-quality medical services to customers worldwide.